Physician

Ahmed Fawzy, M.D

According to 2025 Medicare claims, Ahmed Fawzy, M.D (NPI: 1285664607) practices nephrology in the Cleveland, OH market, with the plurality of this provider's patient population coming from Lorain, OH. This provider's primary affiliated billing organization is NORTH COAST NEPHROLOGY, INC (NPI: 1871529321; TIN: 341898754) and primary practice location at 44035-5902. Fawzy is affiliated with the Mercy Health Select, LLC (ACO ID: A1215), participating under the MSSP model.

Fawzy's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 314 traditional Medicare patients, billed 1,254 HCPCS/CPT codes, and received $137,040 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 1,729 prescription claims across 241 beneficiaries totaling $300,560 in drug costs, led by Jardiance (Empagliflozin). Open Payments data shows 4 records totaling $40. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $242,553 to $137,040. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $196,557 and ending at $300,560. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	641	2,783	$242,553
2016	690	3,129	$277,481
2017	714	3,355	$309,418
2018	575	2,579	$262,442
2019	439	2,036	$218,220
2020	375	1,554	$175,654
2021	452	1,485	$183,299
2022	368	1,273	$150,102
2023	330	1,095	$125,402
2024	314	1,254	$137,040

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	256	1,877	$196,557
2016	262	1,990	$276,080
2017	262	1,951	$376,081
2018	234	1,731	$158,872
2019	205	1,589	$161,991
2020	202	1,600	$92,023
2021	232	1,816	$162,780
2022	230	1,747	$125,003
2023	234	1,686	$130,967
2024	241	1,729	$300,560

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	31	195	$278
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	97	113	$139
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	149	283	$88
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	133	357	$63
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	124	181	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	153	7,394	$142,899
Farxiga	Dapagliflozin Propanediol	103	4,105	$75,582
Cinacalcet Hcl	Cinacalcet Hcl	18	978	$2,575
Torsemide	Torsemide	130	6,430	$1,724
Calcitriol	Calcitriol	44	1,898	$1,185

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$40	Travere Therapeutics, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ahmed Fawzy, M.D?

Tedicare shows public-source Medicare data for Ahmed Fawzy, M.D (NPI 1285664607), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahmed Fawzy, M.D have ACO affiliation data?

Ahmed Fawzy, M.D is shown with ACO affiliation data for Mercy Health Select, LLC (MSSP, ACO ID A1215).

What billing organization is linked to Ahmed Fawzy, M.D?

Ahmed Fawzy, M.D is linked to NORTH COAST NEPHROLOGY, INC (billing NPI 1871529321) in the available physician profile data.

Does Ahmed Fawzy, M.D have Open Payments data?

Ahmed Fawzy, M.D has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.